• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

W.L. Gore & Associates

ESOC 2017 Roundup: Gore touts lowered ischemic stroke, new brain infarcts in PFO Occluder test

May 17, 2017 By Fink Densford

W.L. Gore & Associates yesterday released results from the Reduce study of its Cardioform Septal Occluder devices used to close patent foramen ovale, touting a reduction in recurrent ischemic strokes and new brain infarcts. The Gore Cardioform Septal Occluder is designed to be inserted via catheter and is currently cleared by the FDA for closure […]

Pages: Page 1 Page 2

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Clinical Trials Tagged With: Stryker, W.L. Gore & Associates

Gore wins FDA nod, launches Viatorr Tips endoprosthesis in US

March 9, 2017 By Fink Densford

W.L. Gore & Associates said today it won FDA premarket approval for and launched its Viatorr Tips endoprosthesis with controlled expansion designed for transjugular intrahepatic portosystemic shunt procedures. The Newark, Del.-based company said that the newly cleared Viatorr Tips endoprosthesis is designed with proprietary ePTFE graft lining to minimize transmural permeation of bile and mucin. […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Stent Grafts, Stents Tagged With: W.L. Gore & Associates

Bard logs win in long-running stent graft patent spat with Gore

March 9, 2017 By Fink Densford

A Delaware federal jury awarded a win to  C.R. Bard (NYSE:BCR) in an ongoing spat with W.L. Gore & Associates over ultra thin stent graft patents. The 8-man jury ruled that Bard’s patent does not infringe on Gore’s patent, and that Gore’s patent is invalid, according to court documents released yesterday.. The ruling is the most recent […]

Filed Under: Legal News, Stent Grafts Tagged With: C.R. Bard, W.L. Gore & Associates

Gore wins Health Canada approval for Tigris vascular stent

March 6, 2017 By Fink Densford

W.L. Gore & Associates said today it won Health Canada approval for its Tigris dual-component vascular stent designed to treat peripheral artery disease. The 3rd-generation dual-component stent features a combination of flexible fluoropolymer and single-wire nitinol and is designed to conform to the natural movement of the knee, the Newark, Del.-based company said. “At Gore, […]

Filed Under: Regulatory/Compliance, Stents, Vascular Tagged With: W.L. Gore & Associates

Gore must cough up fees to cover pursuit of sanctions in stent graft spat with Bard

February 9, 2017 By Brad Perriello

A federal judge in Delaware yesterday ordered W.L. Gore & Assoc. to cough up some of the legal fees C.R. Bard (NYSE:BCR) incurred in defending itself against Gore’s bid for sanctions against Bard’s lawyers in their long-running war over stent graft patents. Gore alleged that the Bard legal time conspired to sit on an expert witness report […]

Filed Under: Legal News, Patent Infringement, Stent Grafts Tagged With: C.R. Bard, W.L. Gore & Associates

FDA approves Gore’s Viabahn VBX stent graft for iliac artery lesions

January 30, 2017 By Brad Perriello

W.L. Gore & Assoc. said today that it won FDA approval for its Viabahn VBX stent graft for treating iliac artery lesions, including those found at the aortic bifurcation. Flagstaff, Ariz.-based Gore said the approval means the device is the only balloon-expandable stent graft indicated for the iliac artery. “The VBX stent graft combines radial strength with trackability […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance, Stent Grafts Tagged With: W.L. Gore & Associates

Veith 2016 Roundup: Stent grafts take center stage

November 21, 2016 By Brad Perriello

Medtronic touts Endurant stent graft data from Engage study Medtronic (NYSE:MDT) touted data from a series of sub-group analyses from the 10-year 1,200-patient Engage study of its Endurant II and Endurant IIs stent grafts for treating abdominal aortic aneurysms last week at the annual Veith Symposium on vascular disease. First-time results from a review of […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

Filed Under: Stent Grafts, Stents, Vascular Tagged With: Biotronik, Endologix, Medtronic, Veith Symposium 2016, W.L. Gore & Associates

Gore wins Medicare add-on status for Excluder stent graft

September 27, 2016 By Fink Densford

W.L. Gore & Assoc. said today that it won new technology status from the U.S. Centers for Medicare & Medicaid Services for its Gore Excluder iliac branch endoprosthesis. Set to go into effect Oct. 1, the change will allow facilities that use the device, in conjunction with Gore’s Excluder AAA device for endovascular aneurysm repair, to be eligible […]

Filed Under: Stent Grafts, Vascular Tagged With: Reimbursement, W.L. Gore & Associates

Gore touts 1-year data from Japanese study of Viabahn stent graft

September 21, 2016 By Fink Densford

W.L. Gore & Associates yesterday released 1-year data from a Japanese study of its Viabahn stent graft, touting a nearly 90% primary patency rate at 12 months. Data comes from a 103-patient single-arm study which enrolled a “challenging patient population” with lesions greater than 10cm, Newark, Del.-based Gore said. “Eighty-eight percent is an extremely high […]

Filed Under: Catheters, Clinical Trials, Vascular Tagged With: W.L. Gore & Associates

Gore launches trial for Tag thoracic branch endoprosthesis

September 19, 2016 By Sarah Faulkner

W.L. Gore & Assoc. said today that it enrolled the 1st patient in a pivotal study evaluating its Tag thoracic branch endoprosthesis as a treatment for lesions of the aortic branch and descending thoracic aorta. The Tag TBE is the 1st Gore device to win the FDA’s expedited access pathway designation and among the 1st medical devices […]

Filed Under: Clinical Trials, Endoscopic, Food & Drug Administration (FDA), Regulatory/Compliance, Stent Grafts Tagged With: W.L. Gore & Associates

Gore launches DrySeal Flex introducer sheath

August 30, 2016 By Fink Densford

W.L. Gore & Associates said today it is launching its DrySeal Flex introducer sheath designed for use with its Gore Excluder iliac branch endoprosthesis device, which is used for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms. The newly-launched device is designed with improved flexibility, kink resistance and a hydrophilic coating to […]

Filed Under: Business/Financial News, Catheters, Vascular Tagged With: W.L. Gore & Associates

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS